CRAIGAVON, Northern Ireland--(BUSINESS WIRE)--The Almac Board is delighted to announce the appointment of Kevin Stephens to the executive position of Finance Director, Almac Group, with effect from 1 January 2012.
Kevin will take responsibility for all financial aspects of Almac Group activities globally, leading the financial management teams for all global operations, supporting the planned growth of the business and co-ordinating financial control and reporting throughout the Group.
After graduating from Queen’s University, Belfast, with a degree in Economics, Kevin qualified as a Chartered Accountant with Ernst & Young and then worked for 14 years with Kemira NI as Financial Controller.
Kevin joined the Group in 2001 and following a number of varied financial roles within the organisation he was appointed to the position of Almac UK Group Financial Controller in January 2007. Then in July 2009 he was promoted to the role of VP Finance, Almac Group, and subsequently in October 2010, he was appointed to the Almac Executive team as Executive VP Finance, Almac Group.
Alan Armstrong, CEO of the Almac Group commented: “We are delighted to appoint Kevin to this important financial position on our Board. Not only does he possess strong financial qualifications and training, he also has very specific knowledge and experience of the workings of the Almac Group having held a string of financial positions within the organisation. Indeed, we anticipate that Kevin will play a key strategic role in the continued growth and successful financial management of our Group of companies.”
For media enquiries, please contact Tristan Jervis or Alex Heeley on +44 (0) 207 861 3938 or e-mail: t.jervis@defacto.com.
Notes to Editors
The Almac Group provides a broad range of services from R&D, biomarker discovery and development, API manufacture, formulation development, clinical trial supply and IXRS® technology (IVRS/IWRS), to commercial-scale manufacture. Almac provides services to more than 600 companies, including all the world leaders in the pharmaceutical and biotech sectors.
The company employs over 3,300 individuals and is headquartered in Craigavon, Northern Ireland. US operations are based in Pennsylvania, North Carolina and California. Almac has now moved into its new North American Headquarters located in Souderton PA.